देश: कनाडा
भाषा: अंग्रेज़ी
स्रोत: Health Canada
NON POLLEN
ALK-ABELLO INC
V01AA20
VARIOUS
100000UNIT
LIQUID
NON POLLEN 100000UNIT
INTRADERMAL
5/10/30/50ML
Schedule D
ALLERGENIC EXTRACTS
Active ingredient group (AIG) number: 0109346002; AHFS:
APPROVED
2005-02-02
_Product Monograph Master Template _ _Template Date: September 2020 _ _ALLERGENIC EXTRACTS _ _Page 1 of 16_ PRODUCT MONOGRAPH INCLUDING PATIENT MEDICATION INFORMATION ALLERGENIC EXTRACT POLLENS ALLERGENIC EXTRACT NON POLLENS Allergenic Extracts for Diagnostic Use Only Liquid, Intradermal, Percutaneous ALK-ABELLO INC 35 Channel Drive Port Washington New York United States 11050 Distributed in Canada by: ALK-Abelló Pharmaceuticals, Inc. #35-151 Brunel Road Mississauga, Ontario Canada L4Z 2H6 Submission Control Number: 275814 Date of Revision: January 17, 2024 _ _ _Product Monograph Master Template _ _Template Date: September 2020 _ _ALLERGENIC EXTRACTS _ _Page 2 of 16_ TABLE OF CONTENTS SECTIONS OR SUBSECTIONS THAT ARE NOT APPLICABLE AT THE TIME OF AUTHORIZATION ARE NOT LISTED . TABLE OF CONTENTS .............................................................................................................. 2 PART I: HEALTH PROFESSIONAL INFORMATION ..................................................................... 4 1 INDICATIONS .............................................................................................................. 4 1.1 Pediatrics .......................................................................................................... 4 1.2 Geriatrics........................................................................................................... 4 2 CONTRAINDICATIONS ................................................................................................. 4 3 SERIOUS WARNINGS AND PRECAUTIONS BOX ............................................................ 4 4 DOSAGE AND ADMINISTRATION................................................................................. 5 4.1 Dosing Considerations ....................................................................................... 5 4.2 Recommended Dose and Dosage Adjustment..................................................... 5 4.3 Dilution ................................................................................. पूरा दस्तावेज़ पढ़ें